Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)

Not Applicable

Completed

• Conditions: Cryptosporidiosis; HIV Infections

• Registration Number: NCT00002027
• Lead Sponsor: Janssen, LP

Brief Summary

To evaluate the safety and efficacy of diclazuril capsules compared with placebo capsules as treatment of cryptosporidial related diarrhea in AIDS patients. Treatment efficacy will be based on the drug's clinical results and on its anti-protozoan effects. Safety will be assessed by the occurrence of side effects as reported by patients at their visits and by frequent monitoring of hematology, biochemistries, and urinalysis.

Detailed Description

Not available

Study Timeline

• Status Verified: 1990-06
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (3)

Cornell Univ Med Ctr; 🇺🇸 New York, New York, United States

Saint Luke's - Roosevelt Hosp Ctr; 🇺🇸 New York, New York, United States

Dr Douglas Dieterich; 🇺🇸 New York, New York, United States